SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Meghmani Finechem reports 23% fall in Q4 consolidated net profit

25 Apr 2023 Evaluate

Meghmani Finechem has reported results for fourth quarter (Q4) and year ended March 31, 2023.

Meghmani Finechem has reported fall of 22.49% in its net profit at Rs 76.80 crore for the quarter under review as compared to Rs 99.09 crore for the same quarter in the previous year. However, total income of the company increased by 13.17% at Rs 566.72 crore for Q4FY23 as compared to Rs 500.77 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported fall of 22.57% in its net profit at Rs 76.73 crore for the quarter under review as compared to Rs 99.09 crore for the same quarter in the previous year. However, total income of the company increased by 13.17% at Rs 566.72 crore for Q4FY23 as compared to Rs 500.77 crore for the corresponding quarter previous year.

For the year ended March 31, 2023, the company has reported rise of 39.78% in its net profit at Rs 353.36 crore as compared to Rs 252.79 crore for the previous year. Total income of the company increased by 41.24% at Rs 2,196.38 crore for year under review as compared to Rs 1,555.05 crore for year ended March 31, 2022.

For the year ended March 31, 2023, on the consolidated basis, the company has reported 39.76% rise in its net profit at Rs 353.29 crore as compared to Rs 252.79 crore for the previous year. Total income of the company increased by 41.24% at Rs 2,196.38 crore for year under review as compared to Rs 1,555.05 crore for year ended March 31, 2022.

Epigral Share Price

1328.80 125.55 (10.43%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×